ask="0.680"
ask_size="2500"
average_daily_volume="569053"
bid="0.580"
bid_size="200"
book_value="0.813"
change="+0.005"
change_from_200_day_moving_average="0.041"
change_from_50_day_moving_average="0.004"
change_from_52_week_high="-0.845"
change_From_52_week_low="0.245"
change_in_percent="+0.877%"
close="0.575"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.535"
ebitda="-17.93M"
eps_estimate_current_year="-0.780"
eps_estimate_next_quarter="-0.290"
eps_estimate_next_year="-0.570"
ex_dividend_date="N/A"
float_shares="29627000"
high="0.590"
high_52_weeks="1.420"
last_trade_date="2/16/2017"
last_trade_price="0.575"
last_trade_size="524"
last_trade_time="4:00pm"
low="0.575"
low_52_weeks="0.330"
market_capitalization="17.26M"
moving_average_200_day="0.534"
moving_average_50_day="0.571"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.900"
open="0.589"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+7.759%"
percent_change_from_50_day_moving_average="+0.618%"
percent_change_from_52_week_high="-59.507%"
percent_change_from_52_week_low="+74.242%"
previous_close="0.570"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.701"
price_per_sales="1.544"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="1.110"
stock_exchange="NCM"
symbol="OGXI"
volume="54304"
weeks_range_52="0.330 - 1.420"
